0001035267-18-000121.txt : 20180910
0001035267-18-000121.hdr.sgml : 20180910
20180910104819
ACCESSION NUMBER: 0001035267-18-000121
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180907
FILED AS OF DATE: 20180910
DATE AS OF CHANGE: 20180910
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Friedman Michael A
CENTRAL INDEX KEY: 0001298083
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30713
FILM NUMBER: 181061749
MAIL ADDRESS:
STREET 1: 28903 NORTH AVENUE PAINE
CITY: VALENCIA
STATE: CA
ZIP: 91355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC
CENTRAL INDEX KEY: 0001035267
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 770416458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
BUSINESS PHONE: 4085232100
MAIL ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2018-09-07
0
0001035267
INTUITIVE SURGICAL INC
ISRG
0001298083
Friedman Michael A
1020 KIFER ROAD
SUNNYVALE
CA
94086
1
0
0
0
Common Stock
2018-09-07
4
M
0
1545
271.4833
A
5964
D
Common Stock
2018-09-07
4
S
0
1545
541.4588
D
4419
D
Common Stock
2018-09-07
4
M
0
525
185.7333
A
4944
D
Common Stock
2018-09-07
4
S
0
525
541.4588
D
4419
D
Non-Qualified Stock Option (right to buy)
185.7333
2018-09-07
4
M
0
525
0.0
D
2025-07-23
Common Stock
525
0
D
Non-Qualified Stock Option (right to buy)
271.4833
2018-09-07
4
M
0
1545
0.0
D
2027-04-20
Common Stock
1545
0
D
This transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on August 6, 2019.
Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 1/3rd one year after the date of grant and 1/36th each month thereafter.
Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.
By: Lori Serrano For: Michael A Friedman
2018-09-10